None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Systemically healthy patients, aged Patients affected and diagnosed with moderate to severe aggressive periodontitis as assessed with GI >1; probing depth (PD) > 5mm and clinical attachment loss (CAL) > 3mm with alveolar bone loss affecting > 30% of the teeth as detected on radiograph at the time of initial diagnosis.
Exclusion criteria
Exclusion criteria: Patients with medical disorders like cardiovascular, renal disease, etc. Patients with recent history of acute or chronic infection. Individuals with history of tobacco chewing and smoking. Pregnant and lactating females. Patients with history of periodontal therapy or antibiotic &/or anti-inflammatory medication within previous 6 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvement in GCF Endocan, Vascular Endothelial Growth Factor (VEGF-A) and Tumor Necrosis Factor-α (TNF-α) levels in aggressive periodontitis patientsTimepoint: 3 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Improvement in periodontal status i.e reduction in probing pocket depth and gain in clinical attachment level in aggressive periodontitis patientsTimepoint: 1 and 3 months | — |
Countries
India